Florian Hepp
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 1
-
- Metastasis and carcinoma case studies 1
- Co-authors
- Stephan Braun (11 shared papers)Klaus Pantel (9 shared papers)Christina R.M. Kentenich (8 shared papers)Wolfgang Janni (8 shared papers)Harald Leo Sommer (7 shared papers)Gert Riethmüller (2 shared papers)T. Dimpfl (2 shared papers)Peter Ernst Müller (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (3 papers)European Journal of Cancer (2 papers)New England Journal of Medicine (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Florian Hepp
13 papers receiving 1.7k citations
Florian Hepp's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 645
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 241
- Pathology and Forensic Medicine 126
- Hematology 62
Countries citing papers authored by Florian Hepp
This map shows the geographic impact of Florian Hepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Hepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Hepp more than expected).
Fields of papers citing papers by Florian Hepp
This network shows the impact of papers produced by Florian Hepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Hepp. The network helps show where Florian Hepp may publish in the future.
Co-authors
The 23 scholars most cited alongside Florian Hepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer Hit paper breakdown → | 2000 | 773 |
| 2 | 2000 | 324 | |
| 3 | 2001 | 123 | |
| 4 | Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. | 1999 | 111 |
| 5 | 2001 | 98 | |
| 6 | 1999 | 96 | |
| 7 | 2001 | 65 | |
| 8 | 2001 | 63 | |
| 9 | 2000 | 58 | |
| 10 | 2003 | 22 | |
| 11 | Potential clinical relevance of micrometastatic breast cancer | 1998 | 1 |
| 12 | 1999 | 1 | |
| 13 | 1999 | 1 |
About Florian Hepp
Florian Hepp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Emergency Medicine and Cancer Research, having authored 13 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Hematological disorders and diagnostics (1 paper), Glycosylation and Glycoproteins Research (1 paper), Breast Cancer Treatment Studies (1 paper), Cancer Treatment and Pharmacology (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Cancer Research (645 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (241 citations), Pathology and Forensic Medicine (126 citations) and Hematology (62 citations). Florian Hepp has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Stephan Braun, Klaus Pantel, Christina R.M. Kentenich, Wolfgang Janni, Harald Leo Sommer, Gert Riethmüller, T. Dimpfl, Peter Ernst Müller, Günter Schlimok and Fritz Willgeroth. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, New England Journal of Medicine and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.